Top Banner
Preventing Stroke in Patients Undergoing Cardioversion
25

Preventing Stroke in Patients Undergoing Cardioversion

Dec 31, 2015

Download

Documents

porter-bruce

Preventing Stroke in Patients Undergoing Cardioversion. Anticoagulation in Patients With AF. Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing Cardioversion. X-VeRT Baseline Demographics. X-VeRT Exclusion Criteria. X-VeRT Design. X-VeRT Design. X-VeRT Exclusion Criteria. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Preventing Stroke in Patients Undergoing Cardioversion

Preventing Stroke in Patients Undergoing Cardioversion

Page 2: Preventing Stroke in Patients Undergoing Cardioversion
Page 3: Preventing Stroke in Patients Undergoing Cardioversion

Anticoagulation in Patients With AF

Page 4: Preventing Stroke in Patients Undergoing Cardioversion
Page 5: Preventing Stroke in Patients Undergoing Cardioversion

Other Post-hoc Analyses of NOAC Therapy in Patients Undergoing

Cardioversion

Page 6: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRTBaseline Demographics

Page 7: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Exclusion Criteria

Page 8: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Design

Page 9: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Design

Page 10: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Exclusion Criteria

Page 11: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Design

Page 12: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Primary Efficacy

Page 13: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRTPrimary Efficacy Components

Page 14: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Primary Efficacy

Page 15: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Safety Outcomes

Page 16: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Summary of Results

Page 17: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Summary of Results

Page 18: Preventing Stroke in Patients Undergoing Cardioversion

X-VeRT Study Limitations

Page 19: Preventing Stroke in Patients Undergoing Cardioversion

Treatment of Very Early Onset AF

Page 20: Preventing Stroke in Patients Undergoing Cardioversion

Conclusions

Page 21: Preventing Stroke in Patients Undergoing Cardioversion

Abbreviations

Page 22: Preventing Stroke in Patients Undergoing Cardioversion

Abbreviations (cont)

Page 23: Preventing Stroke in Patients Undergoing Cardioversion

References

Page 24: Preventing Stroke in Patients Undergoing Cardioversion

References (cont)

Page 25: Preventing Stroke in Patients Undergoing Cardioversion

References (cont)